Correlation Between Neurobo Pharmaceuticals and Fortress Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Fortress Biotech Pref, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Fortress Biotech.

Diversification Opportunities for Neurobo Pharmaceuticals and Fortress Biotech

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Neurobo and Fortress is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Fortress Biotech Pref in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech Pref and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech Pref has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Fortress Biotech go up and down completely randomly.

Pair Corralation between Neurobo Pharmaceuticals and Fortress Biotech

Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 1.84 times more return on investment than Fortress Biotech. However, Neurobo Pharmaceuticals is 1.84 times more volatile than Fortress Biotech Pref. It trades about -0.16 of its potential returns per unit of risk. Fortress Biotech Pref is currently generating about -0.38 per unit of risk. If you would invest  285.00  in Neurobo Pharmaceuticals on August 28, 2024 and sell it today you would lose (43.00) from holding Neurobo Pharmaceuticals or give up 15.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Neurobo Pharmaceuticals  vs.  Fortress Biotech Pref

 Performance 
       Timeline  
Neurobo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Fortress Biotech Pref 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fortress Biotech Pref has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Preferred Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Neurobo Pharmaceuticals and Fortress Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurobo Pharmaceuticals and Fortress Biotech

The main advantage of trading using opposite Neurobo Pharmaceuticals and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.
The idea behind Neurobo Pharmaceuticals and Fortress Biotech Pref pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities